Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study Jong‐Mu Sun , Lin Shen , Manish A. Shah +22 more Merck Sharp & Dohme. 2021 The Lancet 1394 citations
Inter-institutional variability in kidney dosimetry during 177Lu-DOTATATE therapy in Japan Noriaki Miyaji , Kenta Miwa , Kosuke Yamashita +19 more 2025 Radiological Physics and Technology 0 citations